Eccrine porocarcinoma is a rare malignant tumor that arises from cells of the eccrine sweat glands. It is characterized by a high potential for invasion and metastasis, which makes the diagnosis and treatment of this disease difficult. The clinical manifestations of eccrine porocarcinoma can vary, but painful nodules or lesions on the skin in areas rich in sweat glands are often observed. Among the most common localizations of the tumor are the hands, back, and neck. Given its aggressive course, early recognition and targeted treatment are important.
History of the disease and interesting historical facts
Eccrine porocarcinoma was first described in medical literature in the mid-20th century. Research conducted at that time revealed the unique morphological structure of this tumor. In 1975, a group of researchers from the United States described eccrine porocarcinomas in detail, comparing them with other types of carcinomas. Interestingly, in some cases, eccrine porocarcinoma was diagnosed in patients who had previously suffered from exotic skin diseases and other cancer-significant conditions. This emphasizes the need for a comprehensive approach to the study and treatment of this disease, including genetic and exogenous factors.
Epidemiology
Eccrine porocarcinoma is a rare disease, with an incidence of approximately 0.005% of all malignant skin tumors. It is most often registered in adult patients, mainly between the ages of 50 and 70. In recent years, there has been an increase in the incidence, which may be due to both improved diagnostic methods and increased smoking and exposure to carcinogens. Recent studies indicate that eccrine porocarcinoma is more common in men than in women and may be associated with certain professions involving prolonged exposure to chemicals.
Genetic predisposition to this disease
To date, scientists have identified several genes that may influence the development of eccrine porocarcinoma. The main genes studied include TP53 and KRAS, which are often mutated in the cells of this tumor. In some cases, excision of genes responsible for tumor suppression is observed. However, the need for further research into the genetic predisposition and mechanisms that contribute to the development of the disease remains relevant for understanding the pathogenesis of eccrine porocarcinoma.
Risk factors for the development of this disease
There are several risk factors that may contribute to the development of eccrine porocarcinoma:
- Exposure to carcinogenic substances such as asbestos, benzene and some chemical dyes.
- Age, since the risk of fears increases with age, especially in patients over 50 years of age.
- Smoking and alcohol abuse, which disrupt metabolism and can contribute to carcinogenesis.
- History of previous skin conditions such as eczema or dermatitis.
- Immunodeficiency states, including HIV infection.
Diagnosis of this disease
Diagnosis of eccrine porocarcinoma requires a careful approach and may include the following methods:
- The main symptoms include the appearance of painful nodules on the skin, itching, redness and inflammation in the area of the tumor.
- Laboratory tests may include blood tests for markers of inflammation and tests for infections.
- Radiologic tests such as ultrasound, computed tomography (CT) scan, and magnetic resonance imaging (MRI) may be used to assess the extent of the tumor.
- Other diagnostic methods, such as skin biopsy, allow a definitive diagnosis to be made based on histological analysis.
- Differential diagnosis includes exclusion of other skin tumors such as basal cell or squamous cell carcinoma.
Treatment
Treatment of eccrine porocarcinoma should be comprehensive and individualized. The main approaches include:
- General treatment involves complete removal of the tumor, which is the most effective method, but is often associated with a high risk of recurrence.
- Pharmacological treatment may include chemotherapeutic agents such as docetaxel and cisplatin for cases where surgery is not possible.
- Surgical treatment involves wide excision of the tumor while preserving healthy tissue.
- Other treatments, such as radiation therapy, are used in cases where there are indications for palliative treatment.
List of medications used to treat this disease
Some of the drugs that may be used in the treatment of eccrine porocarcinoma include:
- Docetaxel
- Cisplatin
- Paclitaxel
- Gemcitabine
- Fluorucil
Disease monitoring
Monitoring the patient's condition after treatment of eccrine porocarcinoma includes control stages and prognosis assessment:
- Regular check-ups with a dermatologist every 3-6 months for the first 2 years, then once a year.
- Evaluation of possible complications such as metastases or recurrence of the disease.
- The prognosis depends on the stage of the disease at the time of diagnosis and successful treatment; relapses may occur in 30-50% cases.
Age-related features of the disease
Eccrine porocarcinoma may present differently in different age groups:
- In elderly patients, the tumor is often diagnosed at a late stage due to untimely seeking medical help.
- In younger people, the disease may be more aggressive and invasion and metastasis are more likely to occur.
- In childhood, eccrine porocarcinoma is extremely rare, and in most cases benign lesions are observed.
Questions and Answers
- What is eccrine porocarcinoma? It is a malignant tumor that develops from the cells of the eccrine sweat glands and can appear as nodules on the skin.
- What are the main symptoms of the disease? The main symptoms include painful nodules on the skin, itching, redness and inflammation.
- How is eccrine porocarcinoma diagnosed? Diagnosis includes biopsy for morphological analysis, as well as radiological studies to assess the extent.
- What are the treatment options for eccrine porocarcinoma? Treatment includes surgical removal, chemotherapy and, in some cases, radiation therapy.
- What is the likelihood of recurrence of the disease? Recurrences may occur in 30-50% cases, which emphasizes the importance of regular follow-up examinations after treatment.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov offers several recommendations for patients with eccrine porocarcinoma:
— Monitor any changes on your skin and at the first sign of anything alarming, consult a doctor.
— Do not neglect regular medical examinations, especially if you have a predisposition to skin diseases.
— Discuss all treatment options with your doctor, including possible side effects and risks.
— Maintain a healthy lifestyle to strengthen your immune system and help your body fight the effects of the disease.
